Long-term patient-reported satisfaction with different inflatable penile prosthesis: Comparison between AMS 700CX and Coloplast Titan

Morgado, Afonso; Cavadas, Ana Sofia Rocha; Pacheco‐Figueiredo, Luís; Tomada, Nuno

doi:10.1016/j.androl.2017.07.003

Cited by 6 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They assessed 55 patients who received either one of the prostheses using the EDITS questionnaire. The study found that there was no difference in satisfaction between patients with Titan® and patients with AMS 700 TM CX [18].…”

Section: Patient and Partner Satisfactionmentioning

confidence: 86%

See 1 more Smart Citation

A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review

Atri¹,

Wong²,

Barengo³

et al. 2020

Cureus

View full text Add to dashboard Cite

There are only two three-piece inflatable penile prostheses (IPP) available to patients in the American market: the AMS (American Medical Systems) 700 TM series (Boston Scientific, Massachusetts) and the Coloplast Titan® series (Coloplast, Minnesota), and data comparing the two are scant. The aim of our study was to summarize the current scientific evidence comparing the two. A systematic literature review was conducted on PubMed. A 10-year filter was placed to include only studies published after Coloplast launched the Titan Touch® release pump. Eligibility criteria included articles discussing specifically the AMS 700 TM and Coloplast Titan® models. Further searches for studies on patient/partner satisfaction were conducted. Abstracts were reviewed to include studies focusing specifically on the models we are studying and studies on patient satisfaction using the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire. The Coloplast device demonstrated slightly greater resistance to the stimulated forces of penetration and gravity. Coloplast implants coated with vancomycin/gentamicin had the highest infection rate followed by the AMS penile prosthesis and the rifampin/gentamicin coating had the lowest infection rate. Prosthesis durability and survival were similar between both brands. Overall satisfaction was high but comparisons are inconsistent. The literature is inconclusive about which device is superior. We suggest randomized, multicenter, prospective studies to help further elucidate the highlights of each product.

show abstract

Section: Patient and Partner Satisfactionmentioning

confidence: 86%

“…No patient with the Titan took longer than 6 months to optimal management. Morgado et al [18] No difference in satisfaction between patients with Titan and patients with AMS 700 CX.…”

Section: Patient and Partner Satisfactionmentioning

confidence: 95%

A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review

Atri¹,

Wong²,

Barengo³

et al. 2020

Cureus

View full text Add to dashboard Cite

show abstract

“…Our research clearly shows that when the highest bilateral and lowest bilateral PSV are considered, the lowest bilateral PSV clearly has a higher correlation with the clinical efficacy, penile rigidity and patient-reported treatment satisfaction (Table 5) When assessing the same variables as predictors of improvement, cure and satisfaction, the lowest PSV shows a fair-to-good ability to predict all three events, while RI on any of the four combinations was a fair predictor of cure and satisfaction, although it was a poor predictor of improvement ( Area under the receiver operating characteristic curve (AUC) are displayed. However, our group has used the same translation in two previous research articles with success (Morgado, Cavadas, Pacheco Figueiredo, & Tomada, 2018;. Clinical improvement was defined as an increase of 4 points in IIEF-5 score between baseline and last valid follow-up visit, and cure was defined as an IIEF-5 higher than 21 points at last valid follow-up visit.…”

Section: Discussionmentioning

confidence: 99%

“…There is no validated translation of the EDITS questionnaire. However, our group has used the same translation in two previous research articles with success (Morgado, Cavadas, Pacheco Figueiredo, & Tomada, 2018;. On the other hand, it is the first research article to correlate patient-reported treatment satisfaction on sildenafil citrate with penile haemodynamics and the first to address the clinical utility and implications of bilateral cavernosal artery recording.…”

Section: Discussionmentioning

confidence: 99%

Is there a role for bilateral peak systolic velocity readings in a penile duplex ultrasound?

2019

Self Cite

View full text Add to dashboard Cite

The penile duplex ultrasound (PDU) has been used as a diagnostic tool in erectile dysfunction (ED) management. It is currently recommended that peak systolic velocity (PSV) and end‐diastolic flow (EDF) should be recorded on both the right and left cavernosal arteries. However, the clinical utility of bilateral recordings is unknown. Our primary objective is to assess the clinical utility of bilateral recordings in ED treatment with sildenafil. A total of 77 patients were included. All patients had a standardised PDU and also completed the IIEF‐5 and started on‐demand treatment with sildenafil at 100 mg at baseline. The IIEF‐5 and EDITS were completed at the 6‐month follow‐up. The Spearman test was used to assess correlation. Receiver operating characteristic (ROC) curves were drawn, and the area under the curve (AUC) was calculated. Improvement, cure and satisfaction were high (77.9%, 64.9% and 67.5%, respectively), and the median IIEF‐5 and EDITS were 25(22; 25) and 81.81(63.63; 88.63) respectively. The lowest PSV had the highest positive correlation with IIEF‐5 and EDITS (p = 0.436 and 0.379, respectively), and it could predict improvement, cure and satisfaction with a fair‐to‐good accuracy (AUC = 0.837, 0.750 and 0.749 respectively). The present study shows bilateral penile blood‐flow assessment is important, and attention should be focused on the lowest bilateral PSV.

show abstract

“…In another study comparing the CX700 with the Titan prosthesis, there was no difference in EDITS score with a mean follow-up time of 58 months (n = 55). 80…”

Section: Patient and Partner Satisfactionmentioning

confidence: 99%

Safety and Efficacy of Inflatable Penile Prostheses for the Treatment of Erectile Dysfunction: Evidence to Date

Wang¹,

Levine²

2022

MDER

View full text Add to dashboard Cite

Erectile dysfunction (ED) is a common problem, and prevalence rates are expected to rise as life expectancy increases worldwide. In more severe cases of ED, penile prosthesis implantation has been an excellent option for patients. Over the past few decades, significant design improvements have been made to the penile prosthesis and modifications to surgical technique to improve clinical outcomes. The purpose of this review is to summarize the safety and efficacy of FDA-approved penile implants in the US market. Design modifications have greatly improved the safety and reliability of the implant. Development of improved surgical techniques has decreased intraoperative injuries and reservoir-related complications. With its high overall satisfaction rates and low risk of complications, the inflatable penile prosthesis remains an excellent option for patients with erectile dysfunction.

show abstract

Long-term patient-reported satisfaction with different inflatable penile prosthesis: Comparison between AMS 700CX and Coloplast Titan

Cited by 6 publications

References 24 publications

A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review

A Comparison Between AMS 700 and Coloplast Titan: A Systematic Literature Review

Is there a role for bilateral peak systolic velocity readings in a penile duplex ultrasound?

Safety and Efficacy of Inflatable Penile Prostheses for the Treatment of Erectile Dysfunction: Evidence to Date

Contact Info

Product

Resources

About